Cryptosporidiosis: host immune responses and the prospects for effective immunotherapies (Q37949643)

25 August 2017

Cryptosporidiosis: host immune responses and the prospects for effective immunotherapies (English)

1 reference

25 August 2017

1 reference

1 reference

Vincent McDonald

1

1 reference

25 August 2017

1 November 2011

1 reference

Expert Review of Anti-infective Therapy

25 August 2017

1 reference

25 August 2017

9

1 reference

25 August 2017

11

1 reference

25 August 2017

1077-1086

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

25 August 2017

1 reference

High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Regulation of homeostasis and inflammation in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Anatomical basis of tolerance and immunity to intestinal antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Epithelial crosstalk at the microbiota-mucosal interface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Mucosal immunity: induction, dissemination, and effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Cryptosporidium parvum activates nuclear factor kappaB in biliary epithelia preventing epithelial cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Differential regulation of beta-defensin gene expression during Cryptosporidium parvum infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Involvement of intestinal epithelial cells in dendritic cell recruitment during C. parvum infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

The cell biology of cryptosporidium infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Cell sorting-assisted microarray profiling of host cell response to Cryptosporidium parvum infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Interferon gamma induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Dysregulation of interferon-gamma-mediated signalling pathway in intestinal epithelial cells by Cryptosporidium parvum infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Roles for NK cells and an NK cell-independent source of intestinal gamma interferon for innate immunity to Cryptosporidium parvum infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Disseminated cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Rapid increase of mucosal CD4 T cells followed by clearance of intestinal cryptosporidiosis in an AIDS patient receiving highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Cryptosporidiosis in rhesus macaques challenged during acute and chronic phases of SIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Mechanisms of innate and acquired resistance to Cryptosporidium parvum infection in SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

An early intestinal mucosal source of gamma interferon is associated with resistance to and control of Cryptosporidium parvum infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Human CD8(+) T cells clear Cryptosporidium parvum from infected intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Association between Cryptosporidium infection and human leukocyte antigen class I and class II alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Cryptosporidium parvum infection in bovine neonates: dynamic clinical, parasitic and immunologic patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Cytokine profile induced by Cryptosporidium antigen in peripheral blood mononuclear cells from immunocompetent and immunosuppressed persons with cryptosporidiosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Humoral immune response in IL-12 and IFN-gamma deficient mice after infection with Cryptosporidium parvum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Mucosal cytokine and antigen-specific responses to Cryptosporidium parvum in IL-12p40 KO mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Exogenous interleukin-12 (IL-12) exacerbates Cryptosporidium parvum infection in gamma interferon knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Cryptosporidium infection in major histocompatibility complex congeneic strains of mice: variation in susceptibility and the role of T-cell cytokine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Cryptosporidium parvum-specific mucosal immune response in C57BL/6 neonatal and gamma interferon-deficient mice: role of tumor necrosis factor alpha in protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Interleukin-4 and transforming growth factor beta have opposing regulatory effects on gamma interferon-mediated inhibition of Cryptosporidium parvum reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Interferon-gamma is required for innate immunity to Cryptosporidium parvum in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Host immune responses against Cryptosporidium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Cooperative role of macrophages and neutrophils in host Antiprotozoan resistance in mice acutely infected with Cryptosporidium parvum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

CD4+ T cells are not essential for control of early acute Cryptosporidium parvum infection in neonatal mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Increased susceptibility of beta7-integrin-deficient neonatal mice in the early stage of Cryptosporidium parvum infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Hyper innate responses in neonates lead to increased morbidity and mortality after infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

MyD88-dependent pathways mediate resistance to Cryptosporidium parvum infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Enzyme immunoassay detection of immunoglobulin M and G antibodies to Cryptosporidium in immunocompetent and immunocompromised persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Longitudinal analysis of cryptosporidium species-specific immunoglobulin G antibody responses in Peruvian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Protective immunity associated with a strong serological response to a Cryptosporidium-specific antigen group, in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Cryptosporidium parvum infection in gene-targeted B cell-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Protection of kids against Cryptosporidium parvum infection after immunization of dams with CP15-DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Characterization and formulation of multiple epitope-specific neutralizing monoclonal antibodies for passive immunization against cryptosporidiosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Past and future: vaccination against Eimeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Molecular targets for detection and immunotherapy in Cryptosporidium parvum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

A recombinant DNA vaccine encoding C. andersoni oocyst wall protein induces immunity against experimental C. parvum infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Immunology of Gut Mucosal Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Retinoic acid induces homing of protective T and B cells to the gut after subcutaneous immunization in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

The genome of Cryptosporidium hominis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Interferon‐γ Expression in Jejunal Biopsies in Experimental Human Cryptosporidiosis Correlates with Prior Sensitization and Control of Oocyst Excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

Adoptive transfer of protective immunity from Cryptosporidium parvum-infected interferon-γ and interleukin-12-deficient mice to naive recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.123

21 January 2018

Identifiers

DOI

10.1586/ERI.11.123

1 reference

25 August 2017

1 reference

PubMed ID

22029525